Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 2
2010 3
2011 4
2012 8
2013 9
2014 4
2016 3
2017 3
2018 6
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Short-term intestinal lipase inhibition in normal-weight individuals does not affect postprandial peptide YY(3-36) and glucagon-like peptide-1 levels, hunger or satiety.
Nguyen NN, Kolobova I, Wolfe BM, Purnell JQ. Nguyen NN, et al. Diabetes Obes Metab. 2020 Dec;22(12):2499-2503. doi: 10.1111/dom.14182. Epub 2020 Sep 23. Diabetes Obes Metab. 2020. PMID: 32869451
PYY(3-36) , GLP-1, hunger and satiety were not different. In conclusion, short-term orlistat administration does not enhance postprandial GLP-1 or PYY(3-36) or affect hunger or satiety in normal-weight individuals. ...
PYY(3-36) , GLP-1, hunger and satiety were not different. In conclusion, short-term orlistat administration does not enhance postpran …
Effects of lipoic acid on walking performance, gait, and balance in secondary progressive multiple sclerosis.
Loy BD, Fling BW, Horak FB, Bourdette DN, Spain RI. Loy BD, et al. Complement Ther Med. 2018 Dec;41:169-174. doi: 10.1016/j.ctim.2018.09.006. Epub 2018 Sep 22. Complement Ther Med. 2018. PMID: 30477834 Free PMC article. Clinical Trial.
TRIAL REGISTRATION: Lipoic Acid for Secondary Progressive Multiple Sclerosis https://clinicaltrials.gov/ct2/show/NCT01188811?term=spain+lipoic+acid&rank=1 NCT0118881....
TRIAL REGISTRATION: Lipoic Acid for Secondary Progressive Multiple Sclerosis https://clinicaltrials.gov/ct2/show/NCT01188811?term=spa …
Opioid-Prescribing Continuity and Risky Opioid Prescriptions.
Hallvik SE, Geissert P, Wakeland W, Hildebran C, Carson J, O'Kane N, Deyo RA. Hallvik SE, et al. Ann Fam Med. 2018 Sep;16(5):440-442. doi: 10.1370/afm.2285. Ann Fam Med. 2018. PMID: 30201641 Free PMC article.
For this retrospective cohort study, we included patients with long-term opioid use, pulling data from Oregon's Prescription Drug Monitoring Program (PDMP), vital records, and hospital discharge registry. ...
For this retrospective cohort study, we included patients with long-term opioid use, pulling data from Oregon's Prescription Drug Mon …
Lessons learned from the implementation of a medically enhanced residential treatment (MERT) model integrating intravenous antibiotics and residential addiction treatment.
Englander H, Wilson T, Collins D, Phoutrides E, Weimer M, Korthuis PT, Calcagni J, Nicolaidis C. Englander H, et al. Subst Abus. 2018;39(2):225-232. doi: 10.1080/08897077.2018.1452326. Subst Abus. 2018. PMID: 29595367 Free PMC article.
We developed a medically enhanced residential treatment (MERT) model integrating residential SUD treatment and long-term IV antibiotics as part of a broader hospital-based addiction medicine service. ...We conducted an ethnographic analysis of interview transcripts and imp …
We developed a medically enhanced residential treatment (MERT) model integrating residential SUD treatment and long-term IV antibioti …
Use of prescription opioids before and after an operation for chronic pain (lumbar fusion surgery).
Deyo RA, Hallvik SE, Hildebran C, Marino M, O'Kane N, Carson J, Van Otterloo J, Wright DA, Millet LM, Wakeland W. Deyo RA, et al. Pain. 2018 Jun;159(6):1147-1154. doi: 10.1097/j.pain.0000000000001202. Pain. 2018. PMID: 29521813 Free PMC article.
We sought to determine what fraction of long-term preoperative opioid users discontinue or reduce dosage postoperatively; what fraction of patients with little preoperative use initiate long-term use; and what predicts long-term postoperative use. ...Overall, …
We sought to determine what fraction of long-term preoperative opioid users discontinue or reduce dosage postoperatively; what fracti …
High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men.
Orwoll ES, Wiedrick J, Jacobs J, Baker ES, Piehowski P, Petyuk V, Gao Y, Shi T, Smith RD, Bauer DC, Cummings SR, Nielson CM, Lapidus J; Osteoporotic Fractures in Men Study (MrOS) Research Group. Orwoll ES, et al. Aging Cell. 2018 Apr;17(2):e12717. doi: 10.1111/acel.12717. Epub 2018 Feb 5. Aging Cell. 2018. PMID: 29399943 Free PMC article.
Overall, these results suggest that complex inflammatory pathways, and proteins in other pathways, are linked to 5-year mortality risk. This work may serve to identify novel biomarkers for near-term mortality....
Overall, these results suggest that complex inflammatory pathways, and proteins in other pathways, are linked to 5-year mortality risk. This …
Trajectories of the relationships of physical activity with body composition changes in older men: the MrOS study.
Laddu DR, Cawthon PM, Parimi N, Hoffman AR, Orwoll E, Miljkovic I, Stefanick ML; Osteoporotic Fractures in Men Study Research Group. Laddu DR, et al. BMC Geriatr. 2017 Jun 5;17(1):119. doi: 10.1186/s12877-017-0506-4. BMC Geriatr. 2017. PMID: 28583069 Free PMC article.
BACKGROUND: Excess adiposity gains and significant lean mass loss may be risk factors for chronic disease in old age. Long-term patterns of change in physical activity (PA) and their influence on body composition decline during aging has not been characterized. ...
BACKGROUND: Excess adiposity gains and significant lean mass loss may be risk factors for chronic disease in old age. Long-term patte …
Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.
Leichtling GJ, Irvine JM, Hildebran C, Cohen DJ, Hallvik SE, Deyo RA. Leichtling GJ, et al. Pain Med. 2017 Jun 1;18(6):1063-1069. doi: 10.1093/pm/pnw251. Pain Med. 2017. PMID: 27794549 Free PMC article.
RESULTS: PDMP use varied from consistent monitoring to checking the PDMP only on suspicion of misuse, with inconsistent use reported particularly among short-term prescribers. Primary care clinicians reported less routine use with existing pain patients than with new patie …
RESULTS: PDMP use varied from consistent monitoring to checking the PDMP only on suspicion of misuse, with inconsistent use reported particu …
41 results